On behalf of every family touched by pancreatic cancer, I am thrilled. My Recalcitrant Cancer Research Act years ago laid a foundation for this breakthrough. As a result, patients today have new hope.
‘Landmark’ pancreatic cancer drug keeps patients alive for twice as long
The highly anticipated results of a clinical trial for the pill, daraxonrasib, have been released, giving doctors hope for treating the stubbornly lethal disease.
washingtonpost.com